One of possible explanations for decreased adiponectin levels in malignancies is the sustained inflammatory status of cancer patients leads to the increased proinflammatory cytokines such as TNF-α and IL-6, which are all reported to suppress adiponectin transcription and translation in adipocyte cell line [118, 119]. This evidence concerns the gene IL6 and cancer.